 |
|
|
|
|
 |
Last Updated: Nov 1, 2009 - 11:48:48 PM |
Latest Research
NIH launches 2009 H1N1 influenza vaccine trials in HIV-infected pregnant women
The first clinical trials to test whether the 2009 H1N1 influenza vaccine can safely elicit a protective immune response in pregnant women launched yesterday, and a trial to conduct the same test in HIV-infected children and youth will begin next week. The International Maternal Pediatric Adolescent AIDS Clinical Trials Group is conducting the studies, which are sponsored and funded by the National Institute of Allergy and Infectious Diseases (NIAID) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), both part of the National Institutes of Health.
Oct 9, 2009 - 3:59:36 AM
|
Latest Research
HIV vaccine regimen demonstrates modest preventive effect in Thailand clinical study
In an encouraging development, an investigational vaccine regimen has been shown to be well-tolerated and to have a modest effect in preventing HIV infection in a clinical trial involving more than 16,000 adult participants in Thailand. Following a final analysis of the trial data, the Surgeon General of the U.S. Army, the trial sponsor, announced today that the prime-boost investigational vaccine regimen was safe and 31 percent effective in preventing HIV infection.
Sep 24, 2009 - 3:59:36 AM
|
Latest Research
Clinical trial of antiretroviral-based HIV prevention strategies for women now under way
A new, large-scale clinical trial is examining whether antiretroviral medications normally used to treat HIV infection can also prevent HIV infection in women when applied as a vaginal gel or taken as oral tablets once daily.
Sep 16, 2009 - 3:59:36 AM
|
Latest Research
ART therapy for babies, mothers safely reduces HIV transmission
Giving daily antiretroviral syrup to breastfeeding infants or treating their HIV-infected mothers with highly active antiretroviral drugs is safe and effective in preventing mother-to-child HIV transmission through breast milk, a study led by University of North Carolina at Chapel Hill investigators has found.
Jul 22, 2009 - 3:59:36 AM
|
Latest Research
New method for HIV testing holds promise for developing world
DURHAM, NC -- A new technique that detects the HIV virus early and monitors its development without requiring refrigeration may make AIDS testing more accessible in sub-Saharan Africa.
Jul 21, 2009 - 3:59:36 AM
|
Latest Research
:
Infectious Diseases
:
AIDS
Treatment with highly active antiretroviral therapy for HIV helps control Hepatitis B
Prolonged use of highly active antiretroviral therapy (HAART) to treat people infected with both HIV and hepatitis B (HBV) helps to better control the hepatitis B infection and could delay or prevent liver complications, according to a new study by researchers at Wake Forest University School of Medicine.
Jul 15, 2009 - 2:12:13 PM
|
Latest Research
Probiotics can increase effectiveness of some antibiotic therapies
Antimicrobial treatments for bacterial vaginosis (BV) are effective, but taking lactobacillus tablets alongside metronidazole antibiotic therapy increases effectiveness over taking this antibiotic alone, according to a Cochrane Systematic Review. The researchers also concluded that intravaginal lactobacillus was as effective as oral metronidazole, although they did note unexplained drop-outs from the trials.
Jul 9, 2009 - 3:59:36 AM
|
Medical News
:
Professionals
:
Doctors
Indian American helps design vaginal ring to prevent HIV transmission
An Indian American endocrinologist has helped develop a vaginal ring that would prevent conception and transmission of HIV infection, by releasing multiple types of non-hormonal agents and microbicides.
Jun 18, 2009 - 12:27:35 PM
|
Latest Research
:
Infectious Diseases
:
AIDS
One step closer to the HIV vaccine
A research team may have broken the stubborn impasse that has frustrated the invention of an effective HIV vaccine, by using an approach that bypasses the usual path followed by vaccine developers.
May 17, 2009 - 11:05:28 AM
|
Latest Research
Humanized mouse infected with HIV vaginally and rectally allows testing
The humanized mouse developed by Dr. J. Victor Garcia-Martinez has allowed the University of Texas Southwestern physician-scientist to conduct HIV/AIDS studies that would have been impossible without such a small animal model of HIV infection. The virus only infects humans and chimpanzees, which are protected as endangered species.
Apr 19, 2009 - 3:59:36 AM
|
Latest Research
Education slowing AIDS in sub-Saharan Africa
Increased schooling across sub-Saharan Africa may be lowering new HIV infections among younger adults, according to sociologists, suggesting a shift in a decades-long trend where formal education is considered an AIDS risk factor.
Mar 22, 2009 - 3:59:36 AM
|
Latest Research
UCSF Transgender HIV Prevention Center funded to provide primary care information
The UCSF Center of Excellence for Transgender HIV Prevention (CoE) has received a grant from The California Endowment that will expand access to information and resources on providing culturally competent health care to trangender individuals.
Mar 12, 2009 - 3:59:36 AM
|
Latest Research
Clinical trial finds microbicide promising as HIV prevention method for women
March 5, 2009 -- A clinical trial involving more than 3,000 women in the U.S. and southern Africa demonstrates for the first time the promise of a vaginal microbicide gel for preventing HIV infection in women. According to findings presented at the Conference on Retroviruses and Opportunistic Infections (CROI), one 0.5 % dose of a microbicide designed to prevent HIV from attaching to cells in the genital tract, was 30% effective. While the results are encouraging, researchers on the study, known as HPTN 035, report that additional evidence is needed to determine more definitively its effectiveness.
Mar 5, 2009 - 4:59:36 AM
|
Latest Research
:
Infectious Diseases
:
AIDS
High rate of HIV treatment interruption among newly released prison inmates
Approximately 80 percent of HIV-infected Texas prison inmates did not fill an initial prescription for antiretroviral therapy within 30 days of their release from prison, potentially increasing their risk for harmful health consequences because of an interruption of treatment, according to a study in the February 25 issue of JAMA.
Feb 25, 2009 - 12:38:05 AM
|
Latest Research
Case Western Reserve University faculty named 2009 NorTech Innovation Award winner
NorTech, in partnership with Crain's Cleveland Business, today presented a 2009 NorTech Innovation Award to Eric J. Arts, Ph.D., for his development of a Biotech Platform to Detect, Monitor, and Treat Viral Diseases. Dr. Arts and his research team developed a set of diagnostic tests used by physicians and researchers to monitor the success of anti-HIV treatment by determining drug resistance and disease strength of the virus. The technology can also be used in academic research to better understand HIV/AIDS and to develop vaccines. Dr. Arts is an Associate Professor of Medicine in the Division of Infectious Diseases, Department of Medicine at Case Western Reserve University School of Medicine. He is also Director of the Uganda Laboratory Core for the Case Western Reserve University Center for Aids Research.
Feb 23, 2009 - 4:59:36 AM
|
Latest Research
UCSF symposium considers biomedical approaches to HIV/AIDS prevention
New and emerging biomedical approaches to HIV/AIDS prevention will be the focus of a daylong symposium on February 24 sponsored by the UCSF-Gladstone Institute for Virology and Immunology Center for AIDS Research (CFAR) and the UCSF Center for AIDS Prevention Studies.
Feb 12, 2009 - 4:59:36 AM
|
Latest Research
Model of pre-exposure prophylaxis against HIV forecasts benefits, potential cost-effectiveness
WHAT: For every two people who begin treatment for HIV infection globally, five others become newly infected. Therefore, preventing new HIV infections is the foremost strategy for ending the HIV/AIDS epidemic. One potential prevention strategy involves giving antiretroviral drug regimens to people who are at high risk for HIV to protect them from infection. Important questions about this experimental approach, known as pre-exposure prophylaxis (PrEP), remain unanswered, including, Could PrEP cut the lifetime risk of HIV infection? Would PrEP be cost-effective?
Feb 9, 2009 - 4:59:36 AM
|
Latest Research
:
Infectious Diseases
:
AIDS
Breast fed babies on Nevirapine prophylaxis are at risk of developing drug-resistant HIV
Babies born to HIV-positive mothers and given the antiretroviral drug nevirapine through the first six weeks of life to prevent infection via breast-feeding are at high risk for developing drug-resistant HIV if they get infected anyway, a team of researchers report.
Jan 5, 2009 - 11:50:26 AM
|
Latest Research
New book covers full spectrum of neuro-AIDS disorders
In the decade-plus since the introduction of highly active antiretroviral therapy (HAART) for HIV infection, doctors have come to understand that the brain can serve as a reservoir for resistant virus, where it causes a whole different set of symptoms scientists call neuro-AIDS. A new book from ASM Press, The Spectrum of Neuro-AIDS Disorders: Pathophysiology, Diagnosis, and Treatment, presents the full scope of research on the neurological and neurobehavioral implications of HIV/AIDS in a single, unique volume.
Dec 9, 2008 - 4:59:37 AM
|
Latest Research
Individuals with HIV have higher risk of non-AIDS cancers
WASHINGTON, D.C. - The risk of non-AIDS cancer is higher for individuals infected with HIV than for the general population, according to a meta-analysis presented here at the American Association for Cancer Research's Seventh Annual International Conference on Frontiers in Cancer Prevention Research.
Nov 18, 2008 - 4:59:37 AM
|
Latest Research
:
Infectious Diseases
:
AIDS
Key protein found that helps HIV assault brain
Washington, Nov 15 - Researchers have isolated a key protein that explains why antiviral drugs can fend off the HIV in the body, but not in the brain.
Nov 16, 2008 - 3:26:04 PM
|
Latest Research
:
Infectious Diseases
:
AIDS
Familes fear HIV transmission if parent is infected
Washington, Nov 6 - Two-thirds of families with an HIV-infected parent experienced fears about the virus spreading at home, according to a joint study.
Nov 11, 2008 - 2:47:23 PM
|
Latest Research
:
Infectious Diseases
:
AIDS
Herpes drug inhibits HIV replication
Washington, Nov 7 - Anti-herpes drug acyclovir can slow down HIV infection by targeting an enzyme, but is also instrumental in the emergence of multi-drug resistant HIV variants.
Nov 11, 2008 - 1:55:19 PM
|
Latest Research
New hope for HIV treatment: Cells exhausted from fighting HIV infection can be revitalized
Researchers at the University of Toronto and the University of California, San Francisco, have revealed new hope for HIV treatment with the discovery of a way to 'rescue' immune cells that are exhausted from fighting off HIV infection.
Nov 10, 2008 - 4:59:37 AM
|
Latest Research
Panel advocates improved understanding of hepatitis B and screening of high-risk populations
Management of hepatitis B is a challenge for physicians and patients due to an incomplete understanding of the disease course, complex treatment indications, and the lack of large studies focusing on important health outcomes. To examine these issues, the NIH convened an independent, impartial panel this week to weigh the available evidence on the management of hepatitis B.
Oct 23, 2008 - 3:59:37 AM
|
Latest Research
Integrating antiretroviral therapy with TB treatment for co-infections reduces mortality
October 16, 2008 -- A South African treatment study conducted by researchers in the Department of Epidemiology at the Mailman School of Public Health shows that mortality among TB-HIV co-infected patients can be reduced by a remarkable 55%, if antiretroviral therapy (ART) is provided with TB treatment at the same time. The randomized, known as the SAPIT (Starting Antiretrovirals at three Points in Tuberculosis) trial, randomly assigned TB-HIV co-infected patients to receive ART. Patients who received ART together with their TB treatment (integrated treatment arm) were compared with patients assigned to receive ART upon completion of TB treatment (sequential treatment arm).
Oct 16, 2008 - 3:59:37 AM
|
Latest Research
HIV drug maraviroc effective for drug-resistant patients
NEW YORK (Oct. 2, 2008) -- As many as one quarter of HIV patients have drug resistance, limiting their treatment options and raising their risk for AIDS and death. Now, maraviroc, the first of a new class of HIV drugs called CCR5 receptor antagonists, has been shown to be effective over 48 weeks for drug-resistant patients with R5 HIV-1, a variation of the virus found in more than half of HIV-infected patients.
Oct 1, 2008 - 3:59:37 AM
|
Latest Research
UNC receives record $181 million grant to evaluate health, poverty and gender programs worldwide
The United States Agency for International Development (USAID) has awarded the Carolina Population Center at the University of North Carolina at Chapel Hill up to $181 million to continue its MEASURE Evaluation project.
Sep 8, 2008 - 3:59:37 AM
|
Latest Research
:
Infectious Diseases
:
AIDS
Combination HIV prevention can avert 12 million cases by 2015
London, Aug 6 - Combination HIV prevention, if thoroughly implemented by governments and communities, can avert 12 million infections by 2015, according to experts. Right now, some 7,000 people are infected daily around the world.
Aug 6, 2008 - 11:02:28 AM
|
Latest Research
HIV expert says 1 step down, 2 more to go in quest to cure AIDS
A Johns Hopkins expert in HIV and how the AIDS virus hides in the body says antiretroviral drugs have stopped HIV from replicating, the first of three key steps needed to rid people of the virus.
Aug 6, 2008 - 3:59:37 AM
|
Latest Research
Stanford study finds HIV drug can persist in mothers' milk, increasing risk to them and their babies
STANFORD, Calif. - A drug commonly used in the developing world to prevent transmission of HIV from mother to child persists in the breast milk and blood of the mothers, putting them and their babies at risk for developing drug-resistant strains of the virus, according to researchers at the Stanford University School of Medicine.
Aug 5, 2008 - 3:59:37 AM
|
Latest Research
:
Infectious Diseases
:
AIDS
Group of HIV patients with inadequate care
A study being presented at this week's International AIDS Conference in Mexico City reveals that these patients frequently lack outpatient health care, do not receive life-saving antiretroviral therapy and continue to engage in risky sexual behavior that likely contributes to HIV transmission.
Aug 4, 2008 - 1:59:44 PM
|
Latest Research
:
Infectious Diseases
:
AIDS
Antiretrovirals do not increase the risk for coronary atherosclerosis
Antiretroviral drugs for HIV do not increase the risk for coronary atherosclerosis, a central risk factor for heart disease, according to a study led by the University of Pittsburgh Graduate School of Public Health to be published in the Aug. 8 issue of the journal AIDS and available online today. The results further suggest that antiretroviral therapy may offer men with HIV some protection against atherosclerosis – hardening of the arteries, caused in part by high levels of cholesterol, smoking and other lifestyle factors.
Aug 4, 2008 - 1:07:25 PM
|
Latest Research
Study highlights risky behavior, lack of care among HIV-infected crack users
Doctors who treat HIV-infected crack users refer to them as the forgotten population. A study being presented at this week's International AIDS Conference in Mexico City reveals that these patients frequently lack outpatient health care, do not receive life-saving antiretroviral therapy and continue to engage in risky sexual behavior that likely contributes to HIV transmission.
Aug 4, 2008 - 3:59:37 AM
|
Latest Research
UGA researchers win $9.2 million stem cell grant from NIH
A research group led by Stephen Dalton, professor and Georgia Research Alliance Eminent Scholar of Molecular Biology at the University of Georgia, has been awarded $9.2 million as part of a major new research grant by the National Institute of General Medical Sciences, part of the National Institutes of Health.
Aug 4, 2008 - 3:59:37 AM
|
Latest Research
New male circumcision device for HIV prevention studied by NewYork-Presbyterian/Weill Cornell
NEW YORK (July 31, 2008) -- With the recent endorsement by the World Health Organization (WHO) and scientists worldwide of adult male circumcision as an important strategy for HIV prevention, there is increased urgency to develop safe and cost-effective circumcision services. This is especially the case in Africa where HIV/AIDS continues to spread at an epidemic rate.
Aug 1, 2008 - 3:59:37 AM
|
Latest Research
ASM and FIND to partner on strengthening infectious disease diagnosis in developing nations
The American Society for Microbiology (ASM) and the Foundation for Innovative New Diagnostics (FIND) have signed a Memorandum of Understanding today confirming their agreement to work in partnership for projects aimed at strengthening infectious disease diagnosis and service integration in resource-poor and transitional countries.
Jul 31, 2008 - 3:59:37 AM
|
Latest Research
:
Infectious Diseases
:
AIDS
Combination anti-retroviral therapy increases life expectancy by greater than 13 years
The life expectancy for patients with human immunodeficiency virus (HIV) has increased by more than 13 years since the late 1990s thanks to advancements in antiretroviral therapy, according to researchers at the University of Alabama at Birmingham (UAB) and Simon Fraser University in Vancouver, British Columbia.
Jul 25, 2008 - 11:29:24 PM
|
Latest Research
:
Infectious Diseases
:
AIDS
HIV-I knocks out immune system faster than thought
Washington, July 19 - The HIV-I virus virtually knocks out the immune system much faster than previously thought.
Jul 19, 2008 - 1:37:12 PM
|
Latest Research
With $2M NIH grant, FSU becomes 1 of world's top imaging centers
TALLAHASSEE, Fla. -- At Florida State University, the collective strength of biomedical research and the scientists who lead it has earned a $2 million High-End Instrumentation (HEI) grant from the National Institutes of Health (NIH). The one-year award will help FSU buy a state-of-the-art robotic electron microscope to advance cutting-edge studies of HIV/AIDS, heart disease, hypertension and cancer.
Jul 16, 2008 - 3:59:37 AM
|
Latest Research
:
Infectious Diseases
:
AIDS
Increased diabetes risk in HIV -positive children; increased cholesterol with some treatments
UC Davis researchers have found, that despite results to the contrary in adults, average cholesterol profiles in young children with HIV do not worsen when they are put on highly active antiretroviral therapy (HAART)--but only when certain combinations of drugs are used. The researchers also found that children beginning or switching to HAART also showed an increase in insulin resistance, potentially raising their risk of developing diabetes later in life
Jul 15, 2008 - 11:44:49 AM
|
Latest Research
New HIV browser gives researchers access to valuable data from vaccine trials
SANTA CRUZ, CA--A new HIV data browser developed by the University of California, Santa Cruz, and the nonprofit organization Global Solutions for Infectious Diseases (GSID) will give researchers access to a wealth of data collected during clinical trials of an AIDS vaccine. Although the vaccine did not succeed in preventing infections, the clinical trial generated a huge amount of valuable data for researchers studying how the virus evolves and causes new infections.
May 29, 2008 - 3:59:37 AM
|
Latest Research
:
Infectious Diseases
:
AIDS
The formation of a HIV particle- imaged
An unlikely duo, a virologist and a biophysicist at Rockefeller University, is making history of their own. By using a specialized microscope that only illuminates the cell’s surface, they have become the first to see, in real time and in plain view, hundreds of thousands of molecules coming together in a living cell to form a single particle of the virus that has, in less than 25 years, claimed more than 25 million lives: HIV.
May 26, 2008 - 4:39:07 AM
|
Latest Research
Scientists identify key roadblock to gene expression
A team of scientists has provided, for the first time, a detailed map of how the building blocks of chromosomes, the cellular structures that contain genes, are organized in the fruit fly Drosophila melanogaster. The work identifies a critical stop sign for transcription, the first step in gene expression, and has implications for understanding how the AIDS virus regulates its genes. The findings will be published in the 15 May 2008 issue of the journal Nature.
May 8, 2008 - 3:59:37 AM
|
Latest Research
Molecular espionage shows a single HIV enzyme's many tasks
CAMBRIDGE, Mass. -- Using ingenious molecular espionage, scientists have found how a single key enzyme, seemingly the Swiss army knife in HIV's toolbox, differentiates and dynamically binds both DNA and RNA as part of the virus' fierce attack on host cells. The work is described this week in the journal Nature.
May 7, 2008 - 3:59:37 AM
|
Latest Research
Stanford researchers synthesize compound to flush HIV out of hiding
Any hunter will tell you that when your quarry goes into hiding, you have to flush it out to get a good shot at it. Such is the case with HIV, the virus that causes AIDS.
May 1, 2008 - 3:59:37 AM
|
Latest Research
UT-ORNL and UCSD researchers find promise in HIV 'switch'
KNOXVILLE -- If the battle against HIV, the virus that causes AIDS, is a chess match, then new research published today gives new insight into one of the virus' most important moves.
Mar 16, 2008 - 3:59:37 AM
|
Latest Research
Scientists say tropics are next emerging disease hotspot
Scientists from four well-known institutions say the next major disease like HIV/AIDS or SARS could occur in any of a number of developing countries concentrated along the equator. They encourage increased surveillance to prevent the spread of a potential outbreak.
Mar 13, 2008 - 3:59:37 AM
|
Latest Research
Novel mathematical model predicts new wave of drug-resistant HIV infections in San Francisco
A mathematical model shows that a new wave of drug-resistant HIV is rising among among men in San Francisco who have sex with men and that this trend will continue over the next few years, according to a new study from the UCLA AIDS Institute.
Feb 17, 2008 - 4:59:37 AM
|
Latest Research
Enzyme structure reveals new drug targets for cancer and other diseases
If the genome is the parts list of the human cell, certain proteins are the production managers, activating and deactivating genes as needed. Scientists funded by the National Institute of General Medical Sciences (NIGMS), part of the National Institutes of Health, now have a clearer understanding of how a key protein controls gene activity and how mutations in the protein may cause disease. The work could provide new avenues to design drugs aimed at cancer, diabetes, HIV, and heart disease.
Feb 14, 2008 - 4:59:37 AM
|
|
|
|
|
| Health |
Musculoskeletal problems ail computer workers
|
Eating less may help you live longer
|
IOM report on national vaccine plan
|
You may damage knees if you're an exercise freak
|
American adults receiving flu vaccine at about the same rate as in 2008, study finds
|
Widowed people have higher mortality
|
Anxious women more likely to have smaller babies
|
UIC receives $1 million grant to study 'fat taxes,' diet, obesity
|
Progress made on group B streptococcus vaccine
|
Exercise addiction could prove fatal
|
| | Healthcare |
Biotech industry hails tax sops in Indian budget
|
Junior doctors in Madhya Pradesh call off strike
|
25000 NRI Doctors Could Return to India from UK
|
AIIMS to guide 40 medical colleges on drug reaction
|
15 percent of Indian women below 50 are obese: Azad
|
Mexico expects swine flu infections to peak at New Year
|
Wipro unveils new application for remote healthcare
|
Azad hikes funds for cancer control, treatment of poor
|
Kerala medical colleges doctors suspend agitation
|
Delhi records 280 cases of dengue
|
| | Latest Research |
Belatacept may preserve renal function better than calcineurin inhibitors in kidney transplantation
|
K-State professor finds link between low oxygen levels in body and cancer-aiding protein
|
HHMI's Gilliam Fellowships aim to increase diversity in the sciences
|
Saving lives one breath at a time
|
Improvements needed in genomic test result discussions
|
Occupational sunlight exposure and kidney cancer risk in men
|
The life and death of online communities
|
Deep sedimentation of acantharian cysts -- a reproductive strategy?
|
Adele Boskey 2010 recipient of ORS/AOA award for lifetime contributions to orthopedics
|
National Jewish Health receives grant to learn how families cope with food allergy
|
| | Medical News |
Azad invites NRI investment in pharmaceuticals, medical education
|
25000 NRI Doctors Could Return to India from UK
|
Eat pistachio to lower blood sugar
|
Stricter resident doctor duty hour required to prevent medical errors
|
Chandigarh adult drinks 11 bottles a month
|
Swine flu vaccine nearing development: Official
|
India to be diabetes' world capital by 2025: Expert
|
US may allow 5,000 more Indian doctors for residency training
|
Scissors taken out from man's stomach after two years
|
India's swine flu toll reaches 967, over 26,000 infected
|
| | Special Topics |
'Primodial Soup' theory for origin of life rejected in paper
|
Human species could have killed Neanderthal man
|
History, geography also seem to shape our genome
|
3,000 Kerala medical students to attend inter-college meet
|
Tamil Nadu seeks to control deemed universities
|
Spiders which eat together, stay together and multiply
|
Anna Hazare - the keeper of the earth and human conscience
|
Indian American scientist wins top IMO prize
|
Artificial human sperm could make men redundant: experts
|
Will autopsy on Benazir's body become necessary?
|
|
|
